Clinical and Echocardiographic Features of Mitral Annular Calcium in Patients Aged ≤50 Years
Related Experiment Video
Updated: Apr 4, 2026

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
Adaya Weissler-Snir1, Daniel Weisenberg1, Sharon Natanzon1
1Department of Cardiology, Rabin Medical Center, Beilinson Hospital, Petah-Tikva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Insights
Mitral annular calcification (MAC) in patients under 50 is linked to higher rates of cardiovascular disease, kidney disease, and aortic valve issues. This finding suggests MAC in young individuals signals broader atherosclerotic disease.
Area of Science:
- Cardiology
- Nephrology
- Valvular Heart Disease
Background:
- Data on mitral annular calcification (MAC) in young patients (<50 years) and associated cardiovascular risks are limited.
- Understanding these associations is crucial for early detection and management in this demographic.
Purpose of the Study:
- To characterize young patients (<50 years) diagnosed with MAC.
- To investigate the association of MAC with cardiovascular risk factors and comorbidities in this population.
Main Methods:
- Prospective enrollment of patients undergoing echocardiography into a database.
- Inclusion of 56 patients aged <50 years with MAC, analyzing clinical, laboratory, and echocardiographic data.
Main Results:
- High prevalence of cardiovascular risk factors (hypertension 53%, diabetes 30%, dyslipidemia 43%, smoking 39%) and established cardiovascular disease (CAD 39%, stroke 19%) in young MAC patients.
- Significant comorbidity with chronic kidney disease (52%), including end-stage renal disease (30%) and renal transplantation (11%).
- Frequent co-occurrence of mitral regurgitation (25%), aortic valve disease (66%), left ventricular hypertrophy (56%), and dysfunction (16%).
Conclusions:
- MAC in young patients serves as a significant marker for underlying atherosclerotic disease.
- The presence of MAC in younger individuals is strongly associated with chronic kidney disease.
- MAC in this age group also indicates a high likelihood of coexisting aortic valve disease.
Abstract:
Data regarding characteristics of young patients with mitral annular calcification (MAC) and its associations with other cardiovascular risk factors are scarce. Hence, we sought to characterize patients aged <50 years with MAC and to examine whether in these patients, MAC is also associated with cardiovascular risk factors. Consecutive patients who underwent an echocardiographic study were prospectively entered into a database. The database included clinical, laboratory, and echocardiographic parameters. The present study included 56 patients aged <50 years with a diagnosis of MAC. The mean age was 44.2 ± 6.9 years with a male-to-female ratio of 2.5:1. The prevalence of cardiovascular risk factors (30 patients [53%] hypertension, 17 patients [30%] diabetes mellitus, 24 patients [43%] dyslipidemia, 22 patients [39%] smoking) and established cardiovascular disease (22 patients [39%] coronary artery disease, 11 patients [19%] previous stroke) was substantially higher than expected for this age group. Twenty-nine patients (52%) had chronic kidney disease. Of these, 18 patients (62%) had end-stage kidney disease and 7 patients (24%) underwent renal transplantation. Fourteen patients (25%) and 3 patients (5%) had moderate or severe mitral regurgitation and mitral stenosis, respectively. Aortic valve disease was present in 37 patients (66%). Moderate or severe left ventricular dysfunction and left ventricular hypertrophy were identified in 9 patients (16%) and 31 patients (56%), respectively. In conclusion, the detection of MAC in a young patient should be regarded as a marker of atherosclerotic disease, chronic kidney disease, and aortic valve disease.
More Related Videos
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
11:04Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
Published on: September 1, 2014
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction